Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q1

7776.TEDINET S100QQQQ
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥31m2023-01-01 → 2023-03-31StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥38m2022-01-01 → 2022-03-31StandaloneNet sales
Operating income−¥182m2023-01-01 → 2023-03-31StandaloneOperating income
Operating income−¥192m2022-01-01 → 2022-03-31StandaloneOperating income
Ordinary income−¥184m2023-01-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥196m2022-01-01 → 2022-03-31StandaloneOrdinary income
Profit before tax−¥184m2023-01-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax−¥198m2022-01-01 → 2022-03-31StandaloneIncome before income taxes
Net income−¥184m2023-01-01 → 2023-03-31StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥199m2022-01-01 → 2022-03-31StandaloneProfit loss
Total assets¥2.0bnat 2023-03-31StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2022-03-31StandaloneTotal assets (5-year summary)
Total liabilities¥399mat 2023-03-31StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥946mat 2022-03-31StandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-6.812023-01-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.982022-01-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio79.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Shares issued27,659,419at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued18,468,119at 2022-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥54m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-03-31−¥115m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-03-31−¥13m
—segment totalrevenue2023-01-01 → 2023-03-31¥31m
—segment totalrevenue external2023-01-01 → 2023-03-31¥31m
—segment totalsegment profit2023-01-01 → 2023-03-31−¥128m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥55m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-03-31−¥116m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-03-31¥38m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-03-31¥38m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-03-31−¥21m
—segment totalrevenue2022-01-01 → 2022-03-31¥38m
—segment totalrevenue external2022-01-01 → 2022-03-31¥38m
—segment totalsegment profit2022-01-01 → 2022-03-31−¥137m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 305
ItemContextValueUnit
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember183035000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember365582000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember399322000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember1467377000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember1785784000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember446957000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember765365000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-759680000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-943673000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-227000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-227000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1154427000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1607249000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember-321000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember24232000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember22942000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1178338000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1629871000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1543920000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember2029194000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember37965000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember30696000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember21552000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember15200000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember16412000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember15496000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember108102000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember111301000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember100088000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember85894000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember208190000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember197196000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-191778000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-181700000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember5000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember636000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember－JPY
Commission fee noiPrior1YTDDuration_NonConsolidatedMember84000JPY
Commission fee noiCurrentYTDDuration_NonConsolidatedMember13000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember3000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember2000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember729000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember21000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember209000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember196000JPY
Stock issuance cost prior noePrior1YTDDuration_NonConsolidatedMember4627000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass